UBS Maintains Buy on Equifax, Raises Price Target to $215

Benzinga Newsdesk www.benzinga.com Positive 76.4%

Neg 0% Neu 0% Pos 76.4%

UBS analyst Kevin Mcveigh maintains Equifax (NYSE:EFX) with a Buy and raises the price target from $212 to $215.

Comments

No comments yet. Be the first!